NCT07314476Not yet recruiting
CardioLogical Interventions and Acute strOke Treatment sTudy
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
The study aims to investigate characteristics and prognosis of ischemic stroke cases following cardiological interventions, focusing on the effectiveness and safety of acute ischemic stroke treatments.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 2 Dec 2025
- Start date
- Jan 2026
- Primary completion date
- Dec 2028
- Lead sponsor
- University of L'Aquila
- Diseases
- Stroke
- NCT number
- NCT07314476
What you commit to
- Study type: Observational
- Planned participants: 400
- From Jan 2026 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Stroke-like symptoms due primarily to another non-ischemic/hemorrhagic acute neurological condition or stroke mimics (e.g. severe hypo- or hyperglycemia, migraine with aura, functional disorders, etc);
- Spontaneous and post traumatic hemorrhagic stroke or spontaneous/post-traumatic subarachnoid hemorrhage or subdural hematoma;
Other
- AciuImpossibility to achieve written informed consent
Who the study is looking for
- acute ischemic stroke in adult patient (18 years of age or older) as diagnosed according to the World Health Organization (WHO) criteria;
- stroke with evidence of CT/MRI DWI/FLAIR acute lesion in the first neuroimaging or in the follow-up at 24-48 h;
- interventional cardiological procedures performed within 28 days since the stroke onset (Percutaneuous Coronary Intervention - PCI, Transcatheter Aortic Valve Replacement - TAVR, Baloon Aortic Valvuloplasy - BAV, Percutaneous Mitral Valve Repair or Replacement, Patent Formaen Ovale - PFO - or Atrial Septal Defects - ASD - Closure, Left Atrial Appendage Closure, Transcatheter Pulmonary Valve Replacement, Percutaneous Closure of Paravalvular Leaks);
- written informed consent provided by the patient himself or by proxy (for unconscious patients, cognitively impaired, or aphasic).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Biotechnological and Applied Clinical Sciences Coordinator of this site? Confirm its status | L’Aquila | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.